Monday, October 26, 2026 · Daily editionET --:--:--

Under way, not recruiting

A Randomized Controlled Trial of Robotic Support for Enhanced Later Life (RoSELL)

NCT07102017 · Shanghai Jiao Tong University School of Medicine · Updated 19 Nov 2025

What is being tested
Co-Design LOVOT Intervention; Standard LOVOT Intervention
For
Loneliness; Well-Being, Psychological; Depression - Major Depressive Disorder
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 65 years and older. About 90 people. The full rules are on the registry page.
Where
China
When
Starts or started 6 May 2025, ends 1 April 2026. Registered 3 Aug 2025.
Results
None posted yet.

In the researchers' words

The purpose of this study is to compare the efficacy of a personalized, co-designed robot interaction against a standardized, fixed robot interaction for reducing loneliness, depression, as well as improving self-agency and quality of life in older adults. This is a three-arm randomized controlled trial. The study will be conducted at a community center in Fuzhou, China, with 100 participants aged 65+ recruited from the facility. The participants will be randomly assigned to one of three conditions: (1) Co-designed robot (CL) group receiving a personalized robot interaction with a structured co-design ceremony; (2) Standard robot (SL) group interacting with an identical robot without personalization features; or (3) An attention-controlled usual care (CU) group. The intervention comprises 16 sessions (two weekly 20-minute sessions over eight weeks). The primary outcomes are loneliness and depressive symptoms. Secondary outcomes include general self-efficacy, quality of life, as well as staff and participants' perceptions of the robot. Mechanism measures (i.e., engagement, self-disclosure) and manipulation checks (e.g., perceived personal role) will be employed to elucidate the underlying theoretical pathways. Data will be collected at baseline (T0), after the initial 2-week co-design period (T1), post-intervention (T2, Week 8), and at 1-month (T3) and 3-month (T4) follow-ups.
ClinicalTrials.gov, NCT07102017

Sites

  • Shanghai Jiao Tong UniversityShanghai, China